查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1790421

美国乳房 MRI 市场规模、份额和趋势分析（按产品、影像技术/造影应用、状况、最终用途和细分市场预测），2025 年至 2033 年

U.S. Breast MRI Market Size, Share & Trends Analysis By Product (Systems, Coils, Software), By Imaging Technique/Contrast Use (CE-MRI, Ab-MRI), By Condition (Malignant, Benign), By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

美国乳房MRI市场摘要

美国乳房 MRI 市场规模预计在 2024 年为 7.9361 亿美元，预计到 2033 年将达到 18.788 亿美元，2025 年至 2033 年的复合年增长率为 10.05%。由于乳癌盛行率上升和医学影像处理需求增加，以及临床试验增加和磁振造影的不断进步，美国对乳房 MRI 的需求正在增加。

乳癌及其他乳房相关疾病的盛行率不断上升，预计将显着推动市场扩张。根据美国国家乳癌基金会（National Breast Cancer Foundation, Inc.）2025年6月发布的数据，美国约八分之一的女性在一生中将被诊断出罹患乳癌。此外，国际癌症研究机构预测，2022年至2050年间，美国乳癌发生率将成长27.8%，到2050年将达到约350,693例。如此显着的癌症发生率成长预计将刺激全美对乳房磁振造影的需求。

此外，越来越多的临床试验评估先进的磁振造影在癌症检测中的应用，并开发创新的影像解决方案，预计将对市场成长做出重大贡献。这些临床试验对于提高诊断准确性、增强早期检测能力以及检验新技术至关重要。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国乳房 MRI 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国乳房MRI市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章：美国乳房MRI市场：产品评估与趋势分析

  • 细分仪表板
  • 美国乳房MRI市场产品差异分析
  • 美国乳房 MRI 市场规模与趋势分析（按产品，2021-2033 年）
  • 系统
  • 线圈
  • 软体

第五章美国乳房MRI市场：影像技术/造影使用估计和趋势分析

  • 细分仪表板
  • 美国乳房MRI市场影像技术/造影使用差异分析
  • 美国乳房 MRI 市场规模及趋势分析（依影像技术/造影应用，2021-2033 年）
  • 造影MRI（CE-MRI）
  • 非造影/简化乳房 MRI（Ab-MRI）

第六章：美国乳房MRI市场：现况评估与趋势分析

  • 细分仪表板
  • 美国乳房MRI市场变化分析
  • 美国乳房 MRI 市场规模及趋势分析（按情况，2021-2033 年）
  • 良性
  • 恶性

第七章美国乳房核磁共振造影系统：最终用途估计与趋势分析

  • 细分仪表板
  • 美国乳房MRI市场最终用途差异分析
  • 美国乳房 MRI 市场规模及趋势分析（依最终用途）（2021-2033 年）
  • 医院和诊所
  • 诊断影像中心
  • 乳癌护理中心
  • 学术研究机构
  • 其他的

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • Innovators
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • US key company market share analysis, 2024
    • GE HealthCare
    • Siemens Medical Solutions USA, Inc.
    • Koninklijke Philips NV
    • Canon Medical Systems
    • Fujifilm Healthcare
    • United Imaging Healthcare Co., Ltd.
    • AURORA HEALTHCARE US CORP
    • QED（Quality Electrodynamics）
    • MR Instruments, Inc.
    • iCAD Inc.
    • Subtle Medical, Inc.
    • Arterys（Tempus）
  • 热图分析/企业市场分析
  • 2024年企业市场占有率预测分析
  • 其他主要市场公司名单
Product Code: GVR-4-68040-656-8

U.S. Breast MRI Market Summary

The U.S. breast MRI market size was estimated at USD 793.61 million in 2024 and is projected to reach USD 1,878.8 million by 2033, growing at a CAGR of 10.05% from 2025 to 2033. The demand for breast MRI in the U.S. is increasing due to the rising prevalence of breast cancer and the growing demand for medical imaging, along with growing clinical trials and continuous technological advancements in magnetic resonance imaging.

The growing prevalence of breast cancer and other breast-related abnormalities is expected to drive market expansion significantly. According to data published by the National Breast Cancer Foundation, Inc. in June 2025, approximately 1 in 8 women in the U.S. will be diagnosed with breast cancer during their lifetime. In addition, projections from the International Agency for Research on Cancer estimate a 27.8% increase in breast cancer incidence in the U.S. between 2022 and 2050, with cases expected to reach approximately 350,693 by 2050. This substantial rise in cancer cases is anticipated to fuel the demand for breast magnetic resonance imaging procedures across the country.

Furthermore, the increasing number of clinical trials evaluating advanced magnetic resonance imaging modalities for cancer detection and developing innovative imaging solutions is expected to contribute significantly to market growth. These trials are crucial in improving diagnostic accuracy, enhancing early detection, and validating new technologies.

U.S. Breast MRI Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast MRI market report based on product, imaging technique/contrast use, condition, and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Systems
    • By MRI System Type
    • Closed MRI Systems
    • Open MRI Systems
    • By Field Strength
    • 1.5 Tesla (1.5T)
    • 3 Tesla (3T)
    • 7 Tesla (7T)
    • By Dimensional Modality
    • 3D Breast MRI
    • 4D Breast MRI
  • Coils
    • By Coil Configuration
    • Unilateral Breast Coils
    • Bilateral Breast Coils
    • By Channel Count
    • 8-Channel Breast Coils
    • 16-Channel (or Higher) Breast Coils
    • By Functionality
    • Diagnostic-Only Coils
    • Biopsy-Compatible Breast Coils
  • Software
  • Imaging Technique / Contrast Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Contrast-Enhanced MRI (CE-MRI)
  • Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
  • Condition Outlook (Revenue, USD Million, 2021 - 2033)
  • Malignant
  • Benign
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Breast Care Centers
  • Academic & Research Institutes
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Imaging Technique/Contrast Use
    • 1.1.3. Condition
    • 1.1.4. End use
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast MRI Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing burden of breast cancer
      • 3.2.1.2. Rising awareness about early diagnosis
      • 3.2.1.3. Favorable government initiatives
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Alternative approaches for breast cancer management
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Rising number of clinical trials
      • 3.2.3.2. Increasing funding and investments
      • 3.2.3.3. Advancements in technology
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Shortage of radiologists
  • 3.3. U.S. Breast MRI Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Breast MRI Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast MRI Market Product Movement Analysis
  • 4.3. U.S. Breast MRI Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Systems
    • 4.4.1. Systems market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.4.1.1. By MRI System Type
        • 4.4.1.1.1. Closed MRI Systems
          • 4.4.1.1.1.1. Closed MRI systems market estimates and forecasts for 2021 - 2033 (USD Million)
        • 4.4.1.1.2. Open MRI Systems
          • 4.4.1.1.2.1. Open MRI systems market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.4.1.2. By Field Strength
        • 4.4.1.2.1. 1.5 Tesla (1.5T)
          • 4.4.1.2.1.1. 1.5 Tesla (1.5T) market estimates and forecasts for 2021 - 2033 (USD Million)
        • 4.4.1.2.2. 3 Tesla (3T)
          • 4.4.1.2.2.1. 3 Tesla (3T) market estimates and forecasts for 2021 - 2033 (USD Million)
        • 4.4.1.2.3. 7 Tesla (7T)
          • 4.4.1.2.3.1. 7 Tesla (7T) market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.4.1.3. By Dimensional Modality
        • 4.4.1.3.1. 3D Breast MRI
          • 4.4.1.3.1.1. 3D breast MRI market estimates and forecasts for 2021 - 2033 (USD Million)
        • 4.4.1.3.2. 4D Breast MRI
          • 4.4.1.3.2.1. 4D breast MRI market estimates and forecasts for 2021 - 2033 (USD Million)
  • 4.5. Coils
    • 4.5.1. Coils market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.5.1.1. By Coil Configuration
        • 4.5.1.1.1. Unilateral Breast Coils
          • 4.5.1.1.1.1. Unilateral breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
        • 4.5.1.1.2. Bilateral Breast Coils
          • 4.5.1.1.2.1. Bilateral breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.5.1.2. By Channel Count
        • 4.5.1.2.1. 8-Channel Breast Coils
          • 4.5.1.2.1.1. 8-channel breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
        • 4.5.1.2.2. 16-Channel Breast Coils
          • 4.5.1.2.2.1. 16-channel breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
      • 4.5.1.3. By Functionality
        • 4.5.1.3.1. Diagnostic-Only Coils
          • 4.5.1.3.1.1. Diagnostic-only coils market estimates and forecasts for 2021 - 2033 (USD Million)
        • 4.5.1.3.2. Biopsy-Compatible Breast Coils
          • 4.5.1.3.2.1. Biopsy-compatible breast coils market estimates and forecasts for 2021 - 2033 (USD Million)
  • 4.6. Software
    • 4.6.1. Software market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast MRI Market: Imaging Technique / Contrast Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast MRI Market Imaging Technique / Contrast Use Movement Analysis
  • 5.3. U.S. Breast MRI Market Size & Trend Analysis, by Imaging Technique / Contrast Use, 2021 to 2033 (USD Million)
  • 5.4. Contrast-Enhanced MRI (CE-MRI)
    • 5.4.1. Contrast-Enhanced MRI (CE-MRI) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.5. Non-Contrast / Abbreviated Breast MRI (Ab-MRI)
    • 5.5.1. Non-Contrast / Abbreviated Breast MRI (Ab-MRI) market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast MRI Market: Condition Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast MRI Market Condition Movement Analysis
  • 6.3. U.S. Breast MRI Market Size & Trend Analysis, by Condition, 2021 to 2033 (USD Million)
  • 6.4. Benign
    • 6.4.1. Benign market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.5. Malignant
    • 6.5.1. Malignant market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 7. U.S. Breast MRI Devices: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Breast MRI Market End Use Movement Analysis
  • 7.3. U.S. Breast MRI Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals and Clinics
    • 7.4.1. Hospitals and clinics market estimates and forecasts for 2021 - 2033 (USD Million)
  • 7.5. Diagnostic Imaging Centers
    • 7.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 - 2033 (USD Million)
  • 7.6. Breast Care Centers
    • 7.6.1. Breast care centers market estimates and forecasts for 2021 - 2033 (USD Million)
  • 7.7. Academic & Research Institutes
    • 7.7.1. Academic & research institutes market estimates and forecasts for 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Others market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. U.S. key company market share analysis, 2024
    • 8.3.4. GE HealthCare
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Siemens Medical Solutions USA, Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Koninklijke Philips N.V.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Canon Medical Systems
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Fujifilm Healthcare
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. United Imaging Healthcare Co., Ltd.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. AURORA HEALTHCARE US CORP
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. QED (Quality Electrodynamics)
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. MR Instruments, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. iCAD Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Subtle Medical, Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Arterys (Tempus)
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
  • 8.4. Heat Map Analysis/ Company Market Position Analysis
  • 8.5. Estimated Company Market Share Analysis, 2024
  • 8.6. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. breast MRI market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. breast MRI market, by imaging technique/contrast use, 2021 - 2033 (USD Million)
  • Table 5 U.S. breast MRI market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. breast MRI market, by condition, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Breast MRI Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 U.S. Breast MRI Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 14 U.S. Breast MRI Market, for Systems, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Breast MRI Market, for Closed MRI Systems, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Breast MRI Market, for Open MRI Systems, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Breast MRI Market, for 1.5 Tesla (1.5T), 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Breast MRI Market, for 3 Tesla (3T), 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Breast MRI Market, for 7 Tesla (7T), 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Breast MRI Market, for 3D Breast MRI, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Breast MRI Market, for 4D Breast MRI, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Breast MRI Market, for Coils, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Breast MRI Market, for Unilateral Breast Coils, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Breast MRI Market, for Bilateral Breast Coils, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Breast MRI Market, for 8-Channel Breast Coils, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Breast MRI Market, for 16-Channel Breast Coils, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Breast MRI Market, for Diagnostic-Only Coils, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Breast MRI Market, for Biopsy-Compatible Breast Coils, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Breast MRI Market, for Software, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Breast MRI Market, for Imaging Technique/Contrast Use, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Breast MRI Market, for Contrast-Enhanced MRI (CE-MRI), 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Breast MRI Market, for Non-Contrast/Abbreviated Breast MRI (Ab-MRI), 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Breast MRI Market, for Conditions, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Breast MRI Market, for Benign, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Breast MRI Market, for Malignant, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Breast MRI Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Breast MRI Market, for Hospitals and Clinics, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Breast MRI Market, for Diagnostic Imaging Centers, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Breast MRI Market, for Breast Care Centers, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Breast MRI Market, for Academic & Research Institutes, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Breast MRI Market, for Others, 2021 - 2033 (USD Million)